Cowen to host conference call to discuss third quarter financial results on Friday, October 29. Click here for more information.

Cronos Group

Buy-side

Financial Advisor, June 2021

Strategic investment in PharmaCann Inc.

Cronos Group is an innovative global cannabinoid company with international production and distribution across five continents. Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology and product development.

More Like This

Jan 2021
$213 Million

Acquisition of Bluma Wellness

Financial Advisor

View Details
May 2020
$85 Million

Acquisition of Reliva, LLC

Exclusive Financial Advisor

View Details
Nov 2019
Hipp Logo

Acquisition of Barnhouse Naturprodukte GmbH

Financial Advisor

View Details